Investigational interstitial lung disease (ILD) drug, efzofitimod, shows early signs of efficacy in patients with pulmonary ...

Patients with connective tissue disease-related interstitial lung disease show slower decline in lung function and longer ...

A 79-year-old man with recurrent oropharyngeal cancer has developed the first documented case of severe drug-induced interstitial lung disease following photoimmunotherapy with cetuximab-sarotalocan ...

Over the past last years, computer vision and deep learning (DL) have completely changed the world. So-called deep neural networks, which capitalize on advancements in processing power and data ...

Background Nintedanib and pirfenidone are antifibrotics approved for use in interstitial lung disease (ILD). Given their significant side effect (SE) burden, regular monitoring of patient adherence, ...

In interstitial lung disease (ILD), quantitative computed tomography (qCT) is effective for prognosticating and for disease monitoring, according to study findings published in European Respiratory ...

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is rare, poorly understood, with heterogeneous characteristics resulting in difficult diagnosis. We aimed to systematically review ...

Chronic lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), are major leading causes of death worldwide and are generally associated with poor ...

Accurate chest X-ray segmentation (CXR) is vital for disease diagnosis and monitoring, such as Covid-19. This study proposes an advanced deep learning-based framework for enhanced CXR segmentation ...